Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
Reborna Biosciences has raised $5.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Reborna Biosciences's investors include ICMG Ventures, Mitsubishi UFJ Capital, Nissay Capital, Takeda, UntroD Capital.
Reborna Biosciences is headquartered in Fujisawa, Japan.
Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
Reborna Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reborna Biosciences — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/reborna-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Reborna Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/reborna-biosciences
{{cite web |title=Reborna Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/reborna-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated